関連する実験動画

Updated: Feb 17, 2026

Studying TGF-β Signaling and TGF-β-induced Epithelial-to-mesenchymal Transition in Breast Cancer and Normal Cells

Studying TGF-β Signaling and TGF-β-induced Epithelial-to-mesenchymal Transition in Breast Cancer and Normal Cells

Published on: October 27, 2020

HB-EGF抑制の複数の戦略:受容体結合への干渉,エクトドメインの脱落,マトリクリンのシグナル伝達

Andrii Siromolot¹, Dariia Zhukova², Svitlana Romaniuk²

¹Department of Molecular Immunology, Palladin Institute of Biochemistry of the NAS of Ukraine, 9 Leontovycha Street, Kyiv, 01054, Ukraine; Department of Technologies of Medical Diagnostics and Treatment, ESC "Institute of Biology and Medicine" of Taras Shevchenko National University of Kyiv, 2 Hlushkova Avenue, Kyiv, 03022, Ukraine.

|February 15, 2026

まとめ

非毒性のディフテリア毒素アナログであるCRM197とSbBは,腫瘍細胞受容体との結合からヘパリン結合型EGF類似成長因子 (HB-EGF) をブロックする. HB-EGFターゲティング戦略を組み合わせることで,がん細胞の増殖を減らし,細胞死を誘発することがあります.

科学分野:

腫瘍学腫瘍学
分子生物学は分子生物学である.
バイオケミストリーバイオケミストリー

背景:

ヘパリン結合型EGF類似成長因子 (HB-EGF) 信号伝達は,腫瘍細胞の増殖と生存に関与しています.
EGFRなどの受容体とのHB-EGFの相互作用とその細胞外マトリックス相互作用をターゲットにすることは,潜在的な治療戦略を提供します.
ディフテリア・トキシン・アナログは,成長因子シグナル伝達経路を干渉するように設計することができます.

研究の目的:

再結合ディフテリア毒素アナログ,CRM197およびBサブユニット (SbB) の,腫瘍細胞受容体へのHB-EGF結合を抑制する効果を評価する.
HB-EGF-ヘパラン硫酸プロテオグリカン (HSPG) 相互作用とプロテアゼ阻害剤の細胞増殖への影響を評価する.
潜在的ながん治療のためのHB-EGFターゲティング戦略の組み合わせ効果を調査する.

主な方法:

フローサイトメトリーは,CRM197とSbB.の存在下で,光HB-EGF誘導体の細胞への結合を測定するために使用されました.
HB-EGF-HSPG相互作用とプロテアゼ阻害剤による細胞増殖抑制を評価するために,MTTアッセイを使用した.
組み合わせ指数 (CI) の計算は,異なる治療薬間の相乗効果または相乗効果の相互作用を評価するために行われました.

主要な成果:

CRM197とSbBは,溶性HB-EGF (sHB-EGF) の細胞表面受容体への結合を効果的に阻害しました.
プロテアゼ阻害剤は,がん細胞に細胞静止性および細胞毒性作用を示した.
ヘパリンは細胞増殖を増加させず,HB-EGFを隔離し,受容体相互作用を防ぐことを示唆しています.

結論:

再結合ディフテリア毒素アナログCRM197およびSbBは,HB-EGF受容体相互作用の効果的な阻害剤である.
HB-EGFを受容体結合とエクトドメインの分離抑制を通じて標的化することは,がん細胞の増殖を減らすための有効な戦略です.
HB-EGFを標的とする組み合わせのアプローチは,EGFRとproHB-EGFの発現率が高い腫瘍における癌細胞死を誘発するのに有望である.

キーワード:

ディフテリア毒素のBサブユニット HB-EGFは,HB-EGFと一致している.ヘパリン (Heparin) とは増殖活動である.プロテアゼ阻害剤プロテアゼ阻害剤 СRM197197 について

さらに関連する動画

Differentiation of Mouse Breast Epithelial HC11 and EpH4 Cells

Differentiation of Mouse Breast Epithelial HC11 and EpH4 Cells

Published on: February 27, 2020

An In Vitro Dormancy Model of Estrogen-sensitive Breast Cancer in the Bone Marrow: A Tool for Molecular Mechanism Studies and Hypothesis Generation

An In Vitro Dormancy Model of Estrogen-sensitive Breast Cancer in the Bone Marrow: A Tool for Molecular Mechanism Studies and Hypothesis Generation

Published on: June 30, 2015

関連する概念動画

Mitogens and the Cell Cycle

Mitogens and the Cell Cycle

Mitogens and their receptors play a crucial role in controlling the progression of the cell cycle. However, the loss of mitogenic control over cell division leads to tumor formation. Therefore, mitogens and mitogen receptors play an important role in cancer research. For instance, the epidermal growth factor (EGF) - a type of mitogen and its transmembrane receptor (EGFR), decides the fate of the cell's proliferation. When EGF binds to EGFR, a member of the ErbB family of tyrosine kinase...

Receptor Downregulation in MVBs

Receptor Downregulation in MVBs

Multivesicular bodies (MVBs) are mature endosomes that sort ubiquitinated proteins and then fuse with lysosomes to degrade the sorted proteins. Epidermal growth factor (EGF) and its receptor (EGFR) form a complex that can be internalized through endocytosis, sorted into an MVB, and later degraded.
The EGFR can initiate signaling pathways that lead to cell proliferation, migration, and differentiation. Overexpression of EGFR stimulates cells to proliferate. Excessive EGFR...

Role of Ephrin-Eph Signalling in Intestinal Stem Cell Renewal

Role of Ephrin-Eph Signalling in Intestinal Stem Cell Renewal

Erythropoietin-producing hepatocellular carcinoma receptor (Eph) and its ligand, Eph receptor-interacting protein (Ephrin) were first discovered in the human carcinoma cell line, hence the name. Ephrin-Eph interaction guides cells to reach their appropriate location in adult tissues. They also play an essential role in the immune system by helping in immune cell migration, adhesion, and activation. Based on their structure and function, Eph is divided into two classes — EphA and EphB.

TGF - β Signaling Pathway

TGF - β Signaling Pathway

The TGF-β signaling pathway regulates cell growth, differentiation, adhesion, motility, and development. TGF-β ligands that induce TGF-β signaling are synthesized in their latent form. Several proteases or cell surface receptors such as integrins act upon the latent form, releasing the active ligand. There are three types of mammalian TGF-βs: (TGF-β1, TGF-β2, and TGF-β3) that bind as homodimers or heterodimers to TGF-β receptors. The TGF-β receptors...

Regulation of Angiogenesis and Blood Supply

Regulation of Angiogenesis and Blood Supply

Rapidly dividing tumors, embryos, and wounded tissues require more oxygen than usual, lowering the oxygen concentration in the blood. At low oxygen or hypoxic conditions, an oxygen-sensitive transcription factor called the hypoxia-inducible factor 1 or HIF1 is activated. HIF1 is a dimeric protein of alpha (ɑ) and beta (β) subunits. Under optimal oxygen conditions, HIF1β is present in the nucleus while HIF1ɑ remains in the cytosol. HIF1ɑ is hydroxylated by prolyl...

Amplifying Signals via Enzymatic Cascade

Amplifying Signals via Enzymatic Cascade

When a ligand binds to a cell-surface receptor, the receptor's intracellular domain changes shape, which may either activate its enzyme function or allow its binding to other molecules. The initial signal is amplified by most signal transduction pathways. This means that a single ligand molecule can activate multiple molecules of a downstream target. Proteins that relay a signal are most commonly phosphorylated at one or more sites, activating or inactivating the protein. Kinases catalyze...